Neurological Diagnostic and Monitoring Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Neurological Diagnostic and Monitoring Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Summary
GlobalData's Medical Devices sector report, “Neurological Diagnostic and Monitoring Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Neurological Diagnostic and Monitoring Equipment pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Neurological Diagnostic and Monitoring Equipment includes Electrical Activity Testing and ICP Monitoring Devices.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Neurological Diagnostic and Monitoring Equipment under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Neurological Diagnostic and Monitoring Equipment and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Neurological Diagnostic and Monitoring Equipment under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
Introduction
Neurological Diagnostic and Monitoring Equipment Overview
Products under Development
Neurological Diagnostic and Monitoring Equipment - Pipeline Products by Stage of Development
Table Neurological Diagnostic and Monitoring Equipment - Pipeline Products by Stage of Development
Table Neurological Diagnostic and Monitoring Equipment - Pipeline Products by Stage of Development
Neurological Diagnostic and Monitoring Equipment - Pipeline Products by Segment
Table Neurological Diagnostic and Monitoring Equipment - Pipeline Products by Segment
Table Neurological Diagnostic and Monitoring Equipment - Pipeline Products by Segment
Neurological Diagnostic and Monitoring Equipment - Pipeline Products by Territory
Table Neurological Diagnostic and Monitoring Equipment - Pipeline Products by Territory
Table Neurological Diagnostic and Monitoring Equipment - Pipeline Products by Territory
Neurological Diagnostic and Monitoring Equipment - Pipeline Products by Regulatory Path
Table Neurological Diagnostic and Monitoring Equipment - Pipeline Products by Regulatory Path
Table Neurological Diagnostic and Monitoring Equipment - Pipeline Products by Regulatory Path
Neurological Diagnostic and Monitoring Equipment - Pipeline Products by Estimated Approval Date
Table Neurological Diagnostic and Monitoring Equipment - Pipeline Products by Estimated Approval Date
Table Neurological Diagnostic and Monitoring Equipment - Pipeline Products by Estimated Approval Date
Neurological Diagnostic and Monitoring Equipment - Ongoing Clinical Trials
Table Neurological Diagnostic and Monitoring Equipment - Ongoing Clinical Trials
Table Neurological Diagnostic and Monitoring Equipment - Ongoing Clinical Trials
Neurological Diagnostic and Monitoring Equipment - Pipeline Products under Development by Companies
Neurological Diagnostic and Monitoring Equipment Companies - Pipeline Products by Stage of Development
Table Neurological Diagnostic and Monitoring Equipment Companies - Pipeline Products by Stage of Development
Neurological Diagnostic and Monitoring Equipment - Pipeline Products by Stage of Development
Table Neurological Diagnostic and Monitoring Equipment - Pipeline Products by Stage of Development
Neurological Diagnostic and Monitoring Equipment Companies and Product Overview
Aalto University Company Overview
Aalto University Pipeline Products & Ongoing Clinical Trials Overview
Table Aalto University Pipeline Products & Ongoing Clinical Trials Overview
Table MEG-MRI Device - Product Status
Table MEG-MRI Device - Product Description
AAT Medical Ltd Company Overview
AAT Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table AAT Medical Ltd - Ongoing Clinical Trials Overview
Table Mente Autism - Phase I/II Study to Assess the Safety and the Efficacy of the Novel NTI/Dolce Strains in a Paediatric Population, along with the Efficacy of the Mente Device When Used in Combination with the Novel NTI/Dolce Medicinal Cannabis Strains
Table Axem Neurotechnology Inc - Ongoing Clinical Trials Overview
Table Axem Home - Portable Method of Motor Rehabilitation Using Functional Near-InfraRed Spectroscopy- Based Braincomputer- interface to Augment Post-stroke Recovery (fNIRS-PROMOTE- Recovery)
Table Next Generation Cerebo - Product Description
Table Bioscan Research Pvt Ltd - Ongoing Clinical Trials Overview
Table Next Generation Cerebo - Assessment of Accuracy, Precision, and Feasibility of a near Infrared Light Device to Detect and Categorize the Intracranial Hematoma in Patients with Suspected Brain Injury Compared to Head CT Scan as the Gold Standard: A Prospective Study
Table Next Generation Cerebo - Assessment of Accuracy, Precision, and Feasibility of CEREBO - a near Infrared Light Device to Detect and Categorize the Intracranial Hematoma in Patients with Suspected Brain Injury Compared to Head Ct Scan as the Gold Standard: A Prospective Study
Table Next Generation Cerebo - Summative Usability Study of a Novel Device - CEREBO for Non Invasive Detection of Intracranial Haemorrhage
Table Next Generation Cerebo - Summative Usability Study of CEREBO in Traumatic Brain Injury Patients to Determine Ease of Use, Ease of Learning and Satisfaction
BioSerenity SAS Company Overview
BioSerenity SAS Pipeline Products & Ongoing Clinical Trials Overview
Table BioSerenity SAS Pipeline Products & Ongoing Clinical Trials Overview
Table Minder - A Prospective Study to Assess the Safety of a Sub-scalp Monitoring Device for the Recording of Brain Electrical Activity Associated with the Occurrence of Epileptic Seizures
Epitel, Inc. Company Overview
Epitel, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table Epitel, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table Infrascanner Model 2000 - Children - Defining the Operating Characteristics of Near-Infrared Spectroscopy (NIRS) in The Diagnosis of Pediatric Traumatic Intracranial Hemorrhage
Innovative Biomedical Instruments and Systems Company Overview
Innovative Biomedical Instruments and Systems Pipeline Products & Ongoing Clinical Trials Overview
Table Innovative Biomedical Instruments and Systems Pipeline Products & Ongoing Clinical Trials Overview
Table Electroencephelograph System - Product Status
Table Electroencephelograph System - Product Description
Instituto de Medicina Genomica SL Company Overview
Instituto de Medicina Genomica SL Pipeline Products & Ongoing Clinical Trials Overview
Table Instituto de Medicina Genomica SL Pipeline Products & Ongoing Clinical Trials Overview
Table Diagnostic Tool - Neurotoxicity - Product Status
Table IRRAflow CNS System - Active Removal of IntraCerebral Hematoma Via Active Irrigation of the Ventricular System
Table IRRAflow CNS System - DIVE: Deployment of Irrigating Intraventricular Catheter System for Intraventricular Hemorrhage
Table IRRAflow CNS System - Study Evaluating the Effectiveness of IRRAflow System in the Treatment of Patients Across Multiple Intracranial Pathologies
Table IRRAflow CNS System - Use of Active Fluid Exchange to Therapeutically Treat Intracranial Bleeding and Infection
Table IRRAflow CNS System - Use of ACTIVE Fluid Exchange to Treat Intraventricular Hemorrhage
Table Kernel Flow Device - A Randomized Study Comparing the Effect of RelieVRx VR Based Program and VR Program on the Brains of Patients with Chronic Pain
Table Kernel Flow Device - IMPACT: Investigating Mild Cognitive Impairment in Patients And Controls With TD-fNIRS
Klick Health Company Overview
Klick Health Pipeline Products & Ongoing Clinical Trials Overview
Table Klick Health Pipeline Products & Ongoing Clinical Trials Overview
Table SymPulse Tele-Empathy Device - Product Status
Table Medfield Diagnostics AB - Ongoing Clinical Trials Overview
Table Strokefinder MD100 - An Open Multicentre Trial on Suspected Stroke Patients Evaluating the Possibility to Use Microwave Technology to Differentiate Hemorrhage from Infarction in the Acute Phase
Table Strokefinder MD100 - Detecting Traumatic Intracranial Hemorrhage with Microwaves and Biomarkers: A Prospective Study Evaluating Ability of Microwave Scanning in Conjunction with Biomarkers to Diagnose Traumatic Intracranial Hemorrhage
Table Strokefinder MD100 - Microwave Imaging in NeuroTrauma (MINT) - a Feasibility Study Investigating Whether Microwavebased Scanning Technology Can Detect an Intra-cranial Bleed in Adult Head Injury Patients
Medisens Wireless, Inc. Company Overview
Medisens Wireless, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table Sense Diagnostics LLC - Ongoing Clinical Trials Overview
Table NeuSTAT - A Prospective, Two-Stage, Non-randomized, Multi-center Within Patient Comparison Study to Evaluate the SENSE Devices Ability to Detect Intracranial Hemorrhage
Table 24/7 EEG SubQ - Children - Product Description
Table EarEEG - Product Status
Table EarEEG - Product Description
Table Hyposafe Subq - Product Status
Table Hyposafe Subq - Product Description
Table UNEEG Medical A/S - Ongoing Clinical Trials Overview
Table Hyposafe Subq - Investigation of Hypoglycaemia-induced EEG Changes in Participants With Type 1 Diabetes by Use of the Hyposafe H02 Device
Table 24/7 EEG SubQ - Evaluation of the 24/7 EEG SubQ System for Ultra Long-Term Recording of Patients with Temporal Lobe Epilepsy An Open-label, Prospective, Paired, Comparative Study
Table 24/7 EEG SubQ - Real World Testing and Cost-effectiveness Analysis of Subcutaneous EEG (REAL-ASE)
Table 24/7 EEG SubQ - Study Title: Evaluation of the 24/7 EEG SubQ System in Subjects with Uncontrolled Genetic Generalised Epilepsy Syndrome
University College Cork Company Overview
University College Cork Pipeline Products & Ongoing Clinical Trials Overview
Table University College Cork Pipeline Products & Ongoing Clinical Trials Overview
Table NEOPRISM - Product Status
Table NEOPRISM - Product Description
University College London Company Overview
University College London Pipeline Products & Ongoing Clinical Trials Overview
Table University College London Pipeline Products & Ongoing Clinical Trials Overview
Table MEG Scanner - Product Status
Table MEG Scanner - Product Description
University of Arizona Company Overview
University of Arizona Pipeline Products & Ongoing Clinical Trials Overview
Table University of Arizona Pipeline Products & Ongoing Clinical Trials Overview
Table Shunt Flow Monitoring Device - Product Status
Neurological Diagnostic and Monitoring Equipment- Recent Developments
Dec 14, 2023: Monash Announces Appointment of appointment of Professor Matthew Nicholson as Pro Vice-Chancellor and President (Indonesia)
Dec 05, 2023: Evolution Optiks Successfully Completes Data Collection in Clinical Study of Neuro- Optical Testing Device
Nov 30, 2023: Senzime Secures Multiple University Hospital Orders in Germany
Nov 17, 2023: Ambu Notice for the Annual General Meeting
Nov 16, 2023: Neuroone Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe
Nov 13, 2023: Zeto Exhibits at Neuroscience 2023 and Will Sponsor EEG Clinical Trials
Nov 08, 2023: Inomed Medizintechnik Receives Additional 510(K) Clearance For ISIS Xpert Plus
Nov 08, 2023: New Study Validates Senzime's Tetragraph Waveforms Using an AI-Based Neural Network
Nov 08, 2023: Invitation to the Presentation of Elekta's Second Quarter 2023/24
Nov 07, 2023: Masimo Announces New Member of the Board of Directors
Nov 06, 2023: Pharma Industry Consortium to Present Data from Large Ketamine-Challenge Study at CNS Summit
Nov 02, 2023: Irras Receives Additional 510(k) Clearance for IRRAflow CNS System
Oct 31, 2023: GE HealthCare Reports Third Quarter 2023 Financial Results
Oct 30, 2023: Ceribell Launches Claritypro AI, Expanding Access to Critical Diagnosis of Electrographic Status Epilepticus
Oct 26, 2023: Integer Holdings Reports Third Quarter 2023 Results
Oct 25, 2023: Cumulus neuroscience presents data at CTAD 2023 annual meeting
Oct 23, 2023: Evoke Neuroscience Elevates Cognitive Health with the Evoke EEG Brain Health System
Oct 13, 2023: Senzime Secures Contract With Top-10 Ranked, US East Coast-Based University Hospital System
Oct 11, 2023: Nihon Kohden Unveils Groundbreaking One View Solution Powered by the Neuromaster G1 for Vital Signs Integration in Intraoperative Neuromonitoring
Oct 11, 2023: Ambu Appoints New Chief Financial Officer
Oct 10, 2023: Cumulus Neuroscience Presents Data at ECNP 2023 Annual Meeting
Oct 09, 2023: Senzime Launches Tetrasensitive, the Market's First Sensor for Neuromuscular Monitoring of Patients With Sensitive Skin
Oct 09, 2023: Ambu Announces Preliminary Financial Results For The Fiscal Year 2022/23
Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
Sep 28, 2023: Premier North America Obtains 510(k) Clearance For Avologi Gel Primer (Model: Av25)
Sep 28, 2023: Integer Schedules Third Quarter 2023 Earnings Release and Conference Call for October 26, 2023
Sep 25, 2023: MCRA Assists Ceribell with Obtaining FDA Breakthrough Device Designation, FDA Marketing Authorization, and CMS NTAP Reimbursement for ClarityPro Device
Sep 19, 2023: BrainScope Receives Investment from the Alzheimer's Drug Discovery Foundation for Alzheimer's Prediction Biomarker
Sep 18, 2023: Senzime Secures Additional Major US Hospital Contract
Sep 15, 2023: Monash University Appoints Chief People Officer
Sep 14, 2023: Beacon Biosignals Receives FDA Clearance for AI-Assisted Sleep Monitoring Device Dreem 3S
Sep 12, 2023: Evolution Optiks Launches Clinical Study of Neuro-Optical Testing Device
Sep 11, 2023: Renowned Radiation Oncologist Joins NYU Langone Perlmutter Cancer Center as Vice Chair for Academic and Faculty Affairs, Director of Brachytherapy
Sep 07, 2023: Philips Reaches Resolution of US Economic Loss Litigation
Sep 05, 2023: Physician Scientist Named Division Chief of Hematology and Medical Oncology at NYU Langone Perlmutter Cancer Center-Sunset Park
Sep 04, 2023: Cortical receives 510(k) clearance from FDA for BARM system version 1
Sep 01, 2023: Senzime Receives Its Largest Order to Date From TOP10 Ranked US Hospital System
Sep 01, 2023: Senzime Receives Its Largest Order to Date from Top-10 Ranked US Hospital System
Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
Aug 24, 2023: Beacon Biosignals Receives 510(k) Clearance for Dreem 3 Headband
Aug 24, 2023: Spark Neuro Receives 510(k) Clearance for SPARK Scan
Aug 24, 2023: Elekta Report from the Annual General Meeting 2023
Aug 23, 2023: Molly Shoichet Joins PRiME as New Scientific Director for Precision Medicine Initiative
Aug 22, 2023: Kernel begins cognitive decline study with neuroimaging technology
Aug 09, 2023: Elekta Announces Invitation of First Quarter 2023/24
Aug 08, 2023: NeuroOne to Report Third Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on August 14
Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024
Aug 07, 2023: New Study Finds That Masimo SedLine Patient State Index (PSi) Has the Potential to Improve Brain Monitoring for Patients Sedated with Dexmedetomidine
Aug 03, 2023: Ceribell Receives FDA 510(k) Clearance and CMS NTAP Reimbursement for New ClarityPro Software with Electrographic Status Epilepticus Diagnostic Indication
Aug 03, 2023: Monash pharmacy Educator Steps into New Leadership Roles
Jul 28, 2023: For the First Time Bioelectronic Medicine Researchers at The Feinstein Institutes Restore Feeling and Lasting Movement in Man Living With Quadriplegia
Jul 20, 2023: Cybin Announces Publication of Sponsored Feasibility Study Validating Kernel's FLOW1 Neuroimaging Technology Measuring Psychedelic Effects on the Brain
Jul 20, 2023: Senzime Receives Large Order from Leading California University Hospital System
Jul 17, 2023: Cumulus Neuroscience Presents Data at AAIC 2023 Annual Meeting and Technology and Dementia Preconference
Jul 14, 2023: Neurobit Technologies Receives 510(k) Clearance for NeuroSwift Pro
Jul 12, 2023: Epitel Receives Additional 510(k) Clearance for REMI Remote EEG Monitoring System
Jul 12, 2023: Cumulus Neuroscience Presents Key Data at the 2023 ENCALS Annual Meeting on Patients with Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)
Jul 03, 2023: New US Study Confirms the Clinical Advantage Of The Tetragraph System for Infants and Young Children
Jul 03, 2023: Senzime Expands Production Capacity Based on Joint Call from European and American Anesthesia Associations and Increasing Market Demand
Jun 30, 2023: Senzime Granted European Patent for Tetrasens
Jun 30, 2023: Renowned Researcher, Founder of Neuroeconomics Named Director of NYU Langone Health's Neuroscience Institute
Jun 29, 2023: Dr. Milos R. Popovic appointed Director of the Institute of Biomedical Engineering at UofT
Jun 28, 2023: Recent Publications Demonstrate Utility of DPNCheck for Identifying High-Risk Diabetes Patients
Jun 19, 2023: BrainMatterZ Receives 510 (k) clearance for SomniCheck
Jun 13, 2023: Ceribell Receives 510(k) Clearance for Status Epilepticus Monitor
Jun 07, 2023: Diabetic Peripheral Neuropathy Screening That Includes DPNCheck Predicts Mortality In A Prospective Clinical Study
Jun 04, 2023: Ad-Tech Medical Instrument receives additional 510(k) clearance for Spencer Probe Depth Electrodes
Jun 01, 2023: Philips and Masimo introduce new, advanced monitoring capabilities to Philips high acuity patient monitors
May 31, 2023: Cumulus Neuroscience completes patient enrollment for pivotal CNS-101 earlystage Alzheimer's dementia validation trial
May 30, 2023: QuantalX receives FDA Breakthrough Designation for diagnosis of normal pressure hydrocephalus and prediction of treatment response
May 22, 2023: Zeto awarded "Best New Neurology Solution" in 2023 by MedTech Breakthrough Awards
May 17, 2023: Nihon Kohden announces consolidated financial results for the fiscal year ended March 31, 2023
May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
May 10, 2023: NeuroOne announces first Clinical Case Using Evo sEEG Electrode Performed at Mayo Clinic
May 09, 2023: GE HealthCare Names James Saccaro Vice President and Chief Financial Officer
May 05, 2023: Cumulus secures FDA approval for dry-sensor EEG headset
May 04, 2023: Elekta announces invitation to the presentation of fiscal year 2022/23
May 02, 2023: NeuroOnea announces U.S. commercial launch of Evo sEEG Electrodes
May 01, 2023: Sensomedical Labs receives FDA 510(k) clearance for SENSOSEEG Depth Electrode
Apr 27, 2023: Cumulus Neuroscience lands coveted iF Design and Red Dot Awards for Innovative At-Home EEG Device
Apr 27, 2023: Integer Holdings reports First Quarter 2023 results
Apr 26, 2023: Senzime announces connectivity with the Masimo Hospital Automation platform
Apr 25, 2023: Niura's EEG-Implemented Earbuds Scan Your Brain Health and Recommend Music to Your Mood
Apr 25, 2023: The Myocene Device Has Been Scientifically Validated for Its Reliability and Consistency for the Objective Measurement of Muscle Fatigue
Apr 18, 2023: New US data confirms that TetraGraph supports clinical decisions and assures patient safety
Apr 12, 2023: Medtronic has a layoff in California
Apr 10, 2023: Henry Ford Health Appoints New Orthopedics Chair and Medical Director
Apr 06, 2023: iMediSync receives 510(k) clearance for iSyncBrain-C Software
Apr 04, 2023: Cadwell launches Arc Voyager for remote wireless access to in-home EEG monitoring with video
Apr 03, 2023: Tetragraph Enables Significant Cost Savings According to Data Presented at Annual Pediatric Meeting in the US
Mar 30, 2023: Integer Schedules First Quarter 2023 Earnings Release and Conference Call for April 27, 2023
Mar 20, 2023: Altoida announces upcoming poster presentations at AD/PD 2023
Mar 16, 2023: Neba Health receives 510(k) clearance for NEBA Compact EEG2R Mobile Headset
Mar 16, 2023: Pharma Consortium publishes results of large EEG/ERP Biomarker study in subjects with schizophrenia and healthy volunteers
Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
Mar 15, 2023: Prolira announces FDA clearance of the DeltaScan Brain State Monitor for detecting acute encephalopathy (acute brain failure), a condition affecting millions of hospitalized patients 60 and older
Mar 09, 2023: Brain Scientific inks major distribution deal with Hansraj Nayyar Medical - India Pvt. Ltd., unlocks largest population's market for NeuroCap and NeuroEEG
Mar 09, 2023: An independent study comparing blink reflex detection device EyeStat to standard lab techniques concludes that the device provides reliable and accurate measures
Mar 08, 2023: Compumedics announces US FDA 510(K) approval for the world's first of its kind Neuro/EEG high-density amplifier Okti
Feb 16, 2023: Compumedics announces US FDA 510(K) approval for the World's First of its kind Neuro/EEG high-density amplifier Okti
Feb 16, 2023: MVAP Medical supplies submits major order for NeuroCaps, sees huge opportunity in pediatrics
Feb 16, 2023: Integer Holdings Reports Results for Fourth Quarter and Full Year 2022
Feb 13, 2023: Prolira receives 510(k) clearance for DeltaScan Patch
Feb 13, 2023: EMSI receives 510(k) clearance for EMSI Garment Electrodes
Feb 13, 2023: IRRAflow system confirmed to more effectively remove collected blood and reduce catheter infection rates than passive drainage in head-to-head analysis
Feb 09, 2023: Senzime Receives Approval for Its Pediatric Sensor in Japan
Feb 08, 2023: Nihon Kohden Announces Consolidated Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2023
Feb 07, 2023: Prolira receives 510(k) clearance for DeltaScan Monitor
Feb 07, 2023: Ambu Announces Interim Report For Q1 2022/23
Feb 06, 2023: Oculogica publishes 5-Site study on its FDA Cleared Concussion Diagnostic
Feb 03, 2023: Inomed Medizintechnik receives 510(k) clearance for C2 Xplore
Feb 01, 2023: New EEG procedure accurately measures distress caused by tinnitus
Jan 31, 2023: Shenzhen Med-link Electronics Tech receives 510(k) clearance for Disposable Noninvasive EEG Sensor
Jan 31, 2023: Elekta's Invitation to the presentation of third quarter 2022/23
Jan 30, 2023: GE HealthCare Reports Fourth Quarter and Full Year 2022 Financial Results
Jan 26, 2023: Brain Scientific partners with SysteMedic, receives first purchase order for NeuroCaps in Israel
Jan 20, 2023: Coapt obtains 510(k) clearance for Alpha Control Liner System (ACLS)
Jan 19, 2023: BioSerenity obtains additional 510(k) clearance for Neuronaute
Jan 17, 2023: GE HealthCare to Announce Fourth Quarter and Full Year 2022 Results on January 30, 2023
Jan 10, 2023: GE HealthCare Announces Preliminary Fourth Quarter and Full Year 2022 Revenue Results; Introduces 2023 Outlook
Dec 27, 2022: Top-Rank Health Care Equipment receives 510(k) clearance for Conductive Gel
Dec 20, 2022: iCE Neurosystems receives 510(k) clearance for iCE-SG2 Subcutaneous Electrode Kit